About Phylos Bioscience
Phylos Bioscience is a company based in Portland (United States) founded in 2014 by Nishan Karassik. Phylos Bioscience has raised $32 million across 12 funding rounds from investors including Organigram, Merida Capital Partners and Accomplice. The company has 61 employees as of December 31, 2020. Phylos Bioscience offers products and services including F1 Hybrid Seeds and Natural THCV Products. Phylos Bioscience operates in a competitive market with competitors including Benson Hill, Cibus, Ceres, Pairwise and Inari, among others.
- Headquarter Portland, United States
- Employees 61 as on 31 Dec, 2020
- Founders Nishan Karassik
-
Sectors
HealthcareAgriculture
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Phylos Bioscience, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$32 M (USD)
in 12 rounds
-
Latest Funding Round
$3 M (USD), Series B
Dec 31, 2025
-
Investors
Organigram
& 3 more
-
Employee Count
61
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Phylos Bioscience
Phylos Bioscience offers a comprehensive portfolio of products and services, including F1 Hybrid Seeds and Natural THCV Products.
Seeds for high-THC cannabis with uniform growth and cost savings.
Enhances cannabis cultivation with unique aromas and traits.
People of Phylos Bioscience
Unlock access to complete
Unlock access to complete
Funding Insights of Phylos Bioscience
Phylos Bioscience has successfully raised a total of $32M across 12 strategic funding rounds. The most recent funding activity was a Series B round of $3 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Phylos Bioscience
Phylos Bioscience has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Organigram, Merida Capital Partners and Accomplice.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Accomplice is engaged in venture capital investments for startups.
|
Locked | Locked | Locked | |
|
Investment firm focused on cannabis industry growth and leadership.
|
Locked | Locked | Locked |
Investor details for Phylos Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Phylos Bioscience
Investment portfolio details for Phylos Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Phylos Bioscience
Detailed financials for Phylos Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Phylos Bioscience Comparisons
Peer comparison for Phylos Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Phylos Bioscience
Phylos Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Benson Hill, Cibus, Ceres, Pairwise and Inari, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of plant-based food ingredients
|
|
| Locked | Locked | Locked |
Gene editing solutions are provided for agriculture.
|
|
| Locked | Locked | Locked |
Beers are produced and branded by Ceres in Italy.
|
|
| Locked | Locked | Locked |
New crop varieties are developed using gene-editing for agrigenomics.
|
|
| Locked | Locked | Locked |
Breeding technology is provided by Inari to design seeds.
|
|
| Locked | Locked | Locked |
Vertical farming and container solutions are developed through research.
|
Detailed competitors of Phylos Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Phylos Bioscience
Complete news archive for Phylos Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Phylos Bioscience
Phylos Bioscience was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Phylos Bioscience is headquartered in Portland, United States. It is registered at Portland, Oregon, United States.
Phylos Bioscience is a funded company, having raised a total of $32M across 12 funding rounds to date.
As of Dec 31, 2020, the latest employee count at Phylos Bioscience is 61.
Phylos Bioscience was founded in 2014 in Portland, United States, within the biotechnology sector focused on cannabis. Tools for plant breeding and sex testing are offered, including kits and cards that detect the Y chromosome in plants aged seven to ten days. Services encompass genetic diagnostics, data analysis, and breeding resources tailored to cannabis cultivation for agricultural and health applications. Operations are centered on transformative plant genetics.
Phylos Bioscience's top competitors include Benson Hill, Cibus and Inari.
Phylos Bioscience offers F1 Hybrid Seeds and Natural THCV Products.
Phylos Bioscience has 4 investors. Key investors include Organigram, Merida Capital Partners, Accomplice, and Entourage Effect Capital.